$PPCH - Dr Kenyon, Chief Scientific Officer of Pro
Post# of 88926
Posted On: 05/22/2014 10:40:22 AM
$PPCH - Dr Kenyon, Chief Scientific Officer of Propanc Health Group, states, "After a detailed strategic review of our scientific and preclinical research, our development team determined I.V. injection as the preferred route of administration. This approach would be the best way to maximise results in future patient trials, by ensuring maximum exposure of the drug to the tumor site." http://finance.yahoo.com/news/propanc-health-...ntentstory
(0)
(0)Scroll down for more posts ▼